
Information Request Email, June 19, 2012 - Octaplas

 
 
 

From:                    Rana, Pratibha

Sent:                      Tuesday, June 19, 2012 11:09 AM

To:                         'Ammons, Stanley'

Cc:                         Rangetiner, Barbara

Subject:                 STN 125416/0 Information Request ( 6-19-12012)

Our Reference: STN 125416/0

Octapharma USA, Inc.

 

Attention: Stanley Ammons

 

Dear Mr. Ammons:

We are reviewing your December 22, 2011 biologics license application (BLA) for Pooled Plasma, Solvent Detergent Treated (Human). We are providing the following comments and request for additional information to continue our review:

 

Chemistry, Manufacturing and Controls (CMC)

 

1.     With regard to the ---(b)(4)------------------ used for the determination of viral clearance, please provide the validation data generated experimentally that the virus would be detected at the theoretical limit of detection in a ---(b)(4)---- for all of the referenced enveloped viruses.

 

The review of this submission is on-going and issues may be added, expanded upon, or modified as we continue to review this submission.

 

Please submit your response to this information request as an amendment to this file by July 3, 2012 referencing the date of this request.

 

The action due date for this file is October 22, 2012.

 

If you have any questions, please contact me.

 

Sincerely,

Pratibha Rana

Pratibha Rana, M.S.

Regulatory Project Manager

 

FDA/CBER/OBRR

Division of Blood Applications

1401 Rockville Pike

Rockville, MD 20852

Office: (301) 827-6124

Fax: (301) 827-2857

email: pratibha.rana@fda.hhs.gov

 

"THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please immediately notify the sender immediately by e-mail or phone."

 